Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Parkinson's Disease

Free Subscription 30.03.2026 3 Ann Neurol 1 BMC Neurol 1 Exp Brain Res 1 J Neuropsychol 4 Lancet Neurol 4 Mov Disord 1 Nat Med 1 Neurobiol Dis 1 Neurochem Res 1 Neuroscience 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. FOX MJ
   The Parkinson Progression Markers Initiative: Why Then? Why Now?
   Ann Neurol. 2026 Mar 23. doi: 10.1002/ana.78192.
   PubMed        
   
   
2. LOEFFLER MA, Klocke P, Wurster I, Lerche S, et al
   Clinical and Biological Determinants of Longitudinal Cognitive Function in Patients With GBA1 Variants and Subthalamic Deep Brain Stimulation.
   Ann Neurol. 2026;99:976-988.
   PubMed         Abstract available
   
   
3. YAN S, Sahoo A, Zerenner T, Marek K, et al
   Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder.
   Ann Neurol. 2026;99:912-921.
   PubMed         Abstract available
   
   

   
   BMC Neurol

4. AVISAR H, Djaldetti R, Krivoy A, Mirelman A, et al
   Parkinson's disease in real life healthcare organization database: a medication-based algorithm.
   BMC Neurol. 2026 Mar 27. doi: 10.1186/s12883-026-04840.
   PubMed        
   
   

   
   Exp Brain Res

5. DONG J, Zhang L, Gao Y, Chen Y, et al
   Knockdown of RNF128 attenuated Parkinson's-induced mitochondrial dysfunction in neurons by stabilizing the SIRT1 protein.
   Exp Brain Res. 2026;244:76.
   PubMed        
   
   

   
   J Neuropsychol

6. WOODROW-HILL C, Bek J, Readman M, Gowen E, et al
   The influence of motor and non-motor characteristics of Parkinson's disease on motor imagery vividness.
   J Neuropsychol. 2026 Mar 26. doi: 10.1111/jnp.70040.
   PubMed         Abstract available
   
   

   
   Lancet Neurol

7. MCLELLAN F
   Miratul Muqit: leading an alliance to decode Parkinson's disease.
   Lancet Neurol. 2026;25:343.
   PubMed        
   
   
8. TRINH J, de Vries NM, Helmich RC, Bloem BR, et al
   Lifestyle interventions for Parkinson's disease - Authors' reply.
   Lancet Neurol. 2026;25:337-338.
   PubMed        
   
   
9. KALBE E, Schaeffer E
   Lifestyle interventions for Parkinson's disease.
   Lancet Neurol. 2026;25:336.
   PubMed        
   
   
10. ALIBUDBUD R
    Lifestyle interventions for Parkinson's disease.
    Lancet Neurol. 2026;25:336-337.
    PubMed        
    
    

    
    Mov Disord

11. OUTEIRO TF, Koss DJ
    Nuclear Alpha-Synuclein: Mechanisms and Implications for Synucleinopathies.
    Mov Disord. 2026;41:603-612.
    PubMed         Abstract available
    
    
12. FLORES-LEON M, Outeiro TF
    Uncovering the Complexity of Synucleinopathies: An Ongoing Tale Between Proteins and Lipids.
    Mov Disord. 2026;41:581-595.
    PubMed         Abstract available
    
    
13. BRADLEY M, Maher S, Espinoza-Vinces C, Gorman K, et al
    Pathogenic Variants in the PRKRA Gene Can Result in a Rapid-Onset Dystonia-Parkinsonism-like Phenotype.
    Mov Disord. 2026 Mar 24. doi: 10.1002/mds.70286.
    PubMed        
    
    
14. SUETTE M, Matic R, Koini M, Gattermeyer-Kell L, et al
    Temporal Dynamics of Parkinson's Disease Tremor: Clinical and Neuroimaging Insights.
    Mov Disord. 2026 Mar 26. doi: 10.1002/mds.70268.
    PubMed         Abstract available
    
    

    
    Nat Med

15. MABROUK OS, Tichler B, Arnold HM, Thoma EC, et al
    LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial.
    Nat Med. 2026 Mar 24. doi: 10.1038/s41591-026-04262.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

16. MOORE J, Rao L, Garcia-Bellido S, Guo F, et al
    Integration of cross-species multi-omics with in vivo experimental validation identifies Parkinson's disease therapeutic targets and novel risk factors within endolysosomal pathway subnetworks.
    Neurobiol Dis. 2026;222:107364.
    PubMed         Abstract available
    
    

    
    Neurochem Res

17. HASSOUNA I, Hassanein OH, El-Elaimy IA, Ibrahim HM, et al
    The Neuroameliorative Effects of Enzymatically Modified Isoquercitrin and Sodium R-lipoate on the Rotenone rat Model of Parkinson's Disease.
    Neurochem Res. 2026;51:120.
    PubMed         Abstract available
    
    

    
    Neuroscience

18. KITCHIGINA VF, Shubina L
    Cannabinoids and cognition in Parkinson's disease: Insights from animal models and emerging clinical evidence.
    Neuroscience. 2026;603:37-49.
    PubMed         Abstract available
    
    

    
    PLoS One

19. CHAMBERS NE, Hall D, Kaplan M, Garan S, et al
    M5 positive allosteric modulation alleviates parkinsonian motor deficits.
    PLoS One. 2026;21:e0345115.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

20. DING M, Chen B, Xiao J, Rong J, et al
    Endogenous ATP-powered nanomotors directing neural stem cell differentiation for Parkinson's disease treatment.
    Proc Natl Acad Sci U S A. 2026;123:e2520119123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum